CROS NT Announces its Expansion into German Market Creating CROS DE GmbH

CROS NT is pleased to announce its expansion into Europe through the creation of CROS DE GmbH, a new wholly-owned subsidiary based in Augsburg, Germany. The company, born from the experience of a German-based CRO, Estimate GmbH, is specialized in providing statistical services to pharmaceuticals and biotechnology industries.
Estimate enrich CROS NT with its expertise and a particular excellence concerning the oncology and dermatology-related research. Estimate was found in 1992 and is a privately held company led by Thomas Zwingers, who is Managing Director. Mr. Zwingers and now also Medical Scientific Director of CROS DE GmbH. Mr. Zwingers has worked in the field of clinical trial since 1980 and has an extremely wide experience in designing and evaluating clinical studies. He has also worked with approximately 70 publications, mostly with clinical partners. During his career he has managed the project team, performed statistical analyses and written statistical reports. In his new position at CROS DE GmbH, Mr. Zwingers will play a leading role in the operations, strategic planning, and corporate development of CROS’s growing portfolio of pharmaceuticals and biotechnology business.
“Mr. Zwingers is an exceptional addition to our team,” said Dr. Paolo Morelli, CROS NT Managing Director. “ “CROS NT is establishing its presence in Germany, his substantial clinical and scientific expertise will be beneficial in expanding into the German market”.

CROS NT is a CRO specializing in clinical data management, statistical analysis, eCRF, ePRO and Life Science Application Hosting services. CROS NT was founded in 1993 and successfully implements high-quality and modern rapid execution applications of clinical study tasks. With CROS DE GmbH there is now the chance to expand CROS NT’s extensive knowledge into Europe.
CROS NT services relies on leading technologies, proven processes and employs experts to deliver on every project's specific requirements with a group of highly-qualified project managers and biostatisticians. The Verona Headquarters currently employs more than 40 people.
CROS NT has completed over 700 studies in a wide range of therapeutic areas like respiratory, oncology, cardiovascular, HIV and Infectious diseases of clinical and observational studies. The clients and partners are pharmaceuticals, biotechnology, medical device and academic organizations in Europe and USA. The reputation has been built on experience, quality, responsiveness to client needs and a passion to achieve the highest performance.
For further information please contact us at info@crosnt.com or visit our website www.crosnt.com

CROS NT srl
Via Germania 2
37135 Verona
Italy
Phone: +39 045 8202666
Fax: +39 045 8205875

This release was published on openPR.